NCT00199030View on ClinicalTrials.gov

Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampath

PHASE2CompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

February 29, 2004

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions

Adult Acute Lymphocytic Leukemia T-cellLymphoma, Lymphoblastic

Interventions

DRUG

Alemtuzumab (MabCampath)

DRUG

Cladribine

Trial Locations (1)

60590

University Hospital, Medical Dept. II, Frankfurt

Sponsors

Lead Sponsor

Goethe University

All Listed Sponsors

lead

Goethe University

OTHER